FACTOR VIII T CELL EPITOPE VARIANTS HAVING REDUCED IMMUNOGENICITY

摘要

Provided herein are methods and compositions for preventing or reducing an initial immune response to factor VIII in patients suffering from hemophilia A, and for reducing the intensity of the immune response in patients having pre-formed inhibitor antibodies against factor VIII.